Gene: HSD17B11
Official Full Name: hydroxysteroid 17-beta dehydrogenase 11provided by HGNC
Gene Summary: Short-chain alcohol dehydrogenases, such as HSD17B11, metabolize secondary alcohols and ketones (Brereton et al., 2001 [PubMed 11165019]).[supplied by OMIM, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22907 | HSD17B11 Knockout cell line (HeLa) | Human | HSD17B11 | 1:3~1:6 | Negative | Online Inquiry |
KO22908 | HSD17B11 Knockout cell line (HCT 116) | Human | HSD17B11 | 1:2~1:4 | Negative | Online Inquiry |
KO22909 | HSD17B11 Knockout cell line (HEK293) | Human | HSD17B11 | 1:3~1:6 | Negative | Online Inquiry |
KO22910 | HSD17B11 Knockout cell line (A549) | Human | HSD17B11 | 1:3~1:4 | Negative | Online Inquiry |
HSD17B11 Gene Knockout Cell Lines represent a cutting-edge tool in genetic research, specifically designed to facilitate studies on the 17-beta hydroxysteroid dehydrogenase type 11 (HSD17B11) gene. This gene is critical in the metabolism of steroid hormones, playing a significant role in various biological processes including hormone biosynthesis, cellular signaling, and reproductive health. The knockout of this gene enables researchers to dissect its functional contributions in a controlled environment and provides insights into the associated pathophysiological conditions.
The key mechanism of these cell lines lies in the targeted disruption of the HSD17B11 gene, achieved through advanced CRISPR-Cas9 technology. This precise gene-editing approach allows for the study of gene function by comparing cellular responses between wild-type and knockout cell lines. Researchers can analyze alterations in steroid metabolism, neuronal differentiation, and cellular response to hormonal stimuli, thus broadening our understanding of endocrine disorders and potential therapeutic targets.
The scientific importance of HSD17B11 Gene Knockout Cell Lines cannot be overstated, as they have applications in both laboratory research and clinical studies. Their utility in evaluating the role of HSD17B11 in diseases such as endometrial cancer, obesity, and metabolic syndrome makes them invaluable in the search for effective treatment strategies and biomarkers.
Compared to existing alternatives, our HSD17B11 Gene Knockout Cell Lines offer unparalleled specificity and reproducibility. While traditional methods of gene silencing such as RNA interference can lead to off-target effects, the CRISPR-Cas9 technology employed ensures a high fidelity knockout, enhancing the reliability of experimental results. Furthermore, these cell lines are validated for consistency and stability, providing researchers with confidence in their findings.
For researchers and clinicians seeking a robust tool for genetic exploration, HSD17B11 Gene Knockout Cell Lines emerge as an essential biomolecular resource. They empower the scientific community to advance our understanding of steroid hormone signaling pathways and open new avenues for therapeutic discovery. Our company, with its extensive experience in molecular biology and commitment to providing innovative solutions, stands ready to support researchers with our expertly developed and rigorously validated product offerings.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.